GemVax & KAEL Co (XKRX:082270) Cash-to-Debt : 1.42 (As of Dec. 2023)

View and export this data going back to 2005. Start your Free Trial

What is GemVax & KAEL Co Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. GemVax & KAEL Co's cash to debt ratio for the quarter that ended in Dec. 2023 was 1.42.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, GemVax & KAEL Co could pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

The historical rank and industry rank for GemVax & KAEL Co's Cash-to-Debt or its related term are showing as below:

XKRX:082270' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.1 Med: 1.77 Max: 6.02
Current: 1.42

During the past 13 years, GemVax & KAEL Co's highest Cash to Debt Ratio was 6.02. The lowest was 0.10. And the median was 1.77.

XKRX:082270's Cash-to-Debt is ranked worse than
53.88% of 993 companies
in the Semiconductors industry
Industry Median: 1.81 vs XKRX:082270: 1.42

GemVax & KAEL Co Cash-to-Debt Historical Data

The historical data trend for GemVax & KAEL Co's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

GemVax & KAEL Co Cash-to-Debt Chart

GemVax & KAEL Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

Get a 7-Day Free Trial

4.77

6.02

5.26

5.96

1.42

GemVax & KAEL Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Cash-to-Debt	Get a 7-Day Free Trial															5.96	4.39	4.51	3.35	1.42

Competitive Comparison of GemVax & KAEL Co's Cash-to-Debt

For the Semiconductor Equipment & Materials subindustry, GemVax & KAEL Co's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GemVax & KAEL Co's Cash-to-Debt Distribution in the Semiconductors Industry

For the Semiconductors industry and Technology sector, GemVax & KAEL Co's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where GemVax & KAEL Co's Cash-to-Debt falls into.

GemVax & KAEL Co Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

GemVax & KAEL Co's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	20700.073	/	(14047.616	+	495.286)
	=	1.42

GemVax & KAEL Co's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	20700.073	/	(14047.616	+	495.286)
	=	1.42

GemVax & KAEL Co (XKRX:082270) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

GemVax & KAEL Co Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of GemVax & KAEL Co's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

GemVax & KAEL Co (XKRX:082270) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Technology » Semiconductors » GemVax & KAEL Co Ltd (XKRX:082270) » Definitions » Cash-to-Debt

Traded in Other Exchanges

N/A

Address

894, Tamnip-Dong, Yuseong-Gu, Daejeon, KOR, 305-510

Website

http://www.kael.co.kr

GemVax & KAEL Co Ltd is primarily engaged in manufacturing and commercializing of coating resin and filters for semiconductors and panel display production. It offers chemical air filter, scrubber resin, and devices for preventing environmental contamination and eliminating harmful gas, for semiconductor and display industry. Its other business operations include research and development of anti-cancer immunotherapeutic and peptide drugs. The company organizes its business operations into three distinct segments: Environmental Pollution Control Business, IT Business, Bio-business. The company's product portfolio consists fundamental products, semiconductor, and display, equipment and system, fire evacuation mask 5aver.

GemVax & KAEL Co (XKRX:082270) Headlines

No Headlines